· Venture Capital Tracker · investment-strategies  · 2 min read

May 2026 NYC Startup Funding: Six Rounds and What They Reveal

May's New York funding sample spans AI infrastructure, retail, wealth management, health, and SMB banking; the useful pattern is measurable workflow adoption.

May’s New York funding sample was not one sector story. It ranged from developer infrastructure and retail inventory to wealth management, health, and SMB banking. The common feature is measurable workflow adoption, not a shared vertical.

Reader job: NYC founders can use the table to find comparable companies and then follow the linked deal pages. This is a selected sample, not a complete New York funding total.

Selected rounds

CompanyRoundAmountCategoryRead
Modal LabsSeries C$355MAI developer infrastructureUsage and developer distribution
RADARSeries B$170MRetail inventory AIStore and customer deployment
FartherSeries D$150MWealth managementAdvisor workflow scale
NourishSeries C$100MMetabolic healthClinical and operational distribution
MomentSeries C$78MInvestment-management AIWorkflow depth
RelayGrowth$50MSMB bankingEmbedded financial operations

What founders should take from the sample

“NYC funding” is not a thesis by itself

The companies above do not share one sector. Geography is useful for finding investors, employees, customers, and peers; it is not a substitute for a market thesis.

Plumbing businesses can raise when the workflow is measurable

Modal, RADAR, Moment, and Relay all sell into operational systems. The useful diligence question is not whether the category sounds exciting, but whether the company can show usage, revenue, retention, or deployment density.

Health and fintech require extra evidence

Nourish and Relay face regulated or trust-sensitive workflows. Their rounds should be compared using clinical, distribution, or financial-operating evidence—not only headline valuation.

Method and sources

The list is limited to selected May announcements with relevant VCT coverage. Amounts are not summed, and the page does not claim to represent every NYC financing. Sources include Crunchbase News, AlleyWatch, and VC News Daily:

https://vcnewsdaily.com/ https://news.crunchbase.com/venture/biggest-funding-rounds-medical-devices-futuristic-ai-gadgets-frontier-labs-mirus/ https://alleywatch.com/2026/05/the-weekly-notable-startup-funding-report-5-25-26/

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Back to Blog

Recommended next

Browse all research »

How Much Did AusperBio Raise? $120M Series C, No Valuation

AusperBio closed a $120 million Series C on August 27, 2026. An unnamed strategic investor led. RA Capital joined. The company cites $360 million raised since 2024. Valuation was not disclosed. AHB-137 is in Phase 3 in China and remains investigational.